Dr. Sarah Tabbutt is a pediatric cardiologist and director of the Pediatric Cardiac Intensive Care Unit at UCSF Benioff Children's Hospital. She cares for infants and children recovering from high-risk heart surgery.
In her research, Tabbutt studies neurodevelopmental outcomes in newborns after heart surgery, with a particular focus on those with a birth defect called hypoplastic left heart syndrome. She is a primary investigator in the first multicenter surgical trial sponsored by the National Institutes of Health's Pediatric Heart Network to compare outcomes between two types of shunts (devices placed to redirect blood flow) for first-stage treatment of hypoplastic left heart syndrome.
Before medical school, Tabbutt earned a doctorate in physical chemistry at the University of California, Berkeley. She earned her medical degree and completed a pediatric residency at the University of California, San Diego. She completed fellowships in pediatric cardiology and pediatric critical care medicine at Boston Children's Hospital.
Tabbutt is on the board of directors of the Pediatric Cardiac Intensive Care Society. Before joining UCSF, she directed cardiac intensive care at Children's Hospital of Philadelphia.